Our proprietary high performance nanoliter-scale immunoassay platforms, Gyrolab xPand and Gyrolab xPlore, are used by scientists in leading pharmaceutical, biotech, CRO, and CMO companies

Bioanalytical applications include pharmacokinetics/pharmacodynamics, immunogenicity, affinity,product titer and quantitating bioprocess-related impurities.

Our Innovation Timeline

history-1988-1999

1988-1999

Amersham Pharmacia Biotech. Project on miniaturization and microfluidics.

history-2000

2000

Gyros AB formed. Spin off from Amersham Pharmacia Biotech.

history-2002

2002

Gyrolab Maldi SP1. First instrument for purifying protein samples for analysis by MALDI MS.

history-2003

2003

Gyrolab Workstation and Bioaffy 200 CD. First immunoassay system for nanoliter-scale protein quantification launched at DDT in Boston.

history-2006

2006

Cambridge Antibody Technologies (now Medimmune) purchases first system for use in biotherapeutic development.

Download Case Study: One Mouse, One PK…the Magic of Capillary Microsampling and Gyrolab

Download
history-2009

2009

Gyrolab xP launched with software designed for 21 CFR part 11 compliance and extended validation support.

history-2011

2011

Launch of ADA solution. New mixing CD and software for analysis of anti-drug antibodies.

history-2014

2014

Gyrolab Protein A kit launched.

history-2015

2015

Gyrolab xPlore launched, a single CD compact alternative to the Gyrolab xP.

Gyrolab CHO-HCP and huIgG titer kits expand the bioprocess kit menu.

history-2016

2016

Gyrolab Affinity software launched.

Gyros Protein Technologies formed by the merger of Gyros AB and Protein Technologies, Inc.

history-2017

2017

Launch of

  • Gyrolab Generic PK Kit
  • New ADA solution
  • Updated Protein A Kit

 

history-2018

2018

Launch of Gyrolab xPand

  • Cooling of samples and reagents
  • Mix and match methods/CDs in a single run

 

history-2019

2019

Launch of:

  • Gyrolab E. coli HCP Kit
  • Gyrolab CHO-HCP E3G Kit
  • Gyrolab p24 Kit
  • Gyrolab Bioaffy 1000 HC Assay Toolbox

Acquisition of Gyros Protein Technologies by Mesa Laboratories, Inc.

  • Gyros Protein Technologies is now a division of Mesa Laboratories
history-2020

2020

Gyrolab® AAV Titer Kit
Accelerate AAV vector titer measurement with 10x less samples

Gyrolab® Bioaffy 1000 HC
Improved performance for low affinity reagents

history-2021

2021

Gyrolab® Bioaffy™ 4000 CD
for increased immunoassay sensitivity

Launch of:
Ready to use Solutions for Gyrolab® with reagent sets from Cygnus that are developed for use with the Gyrolab technology.

HEK 293 HCP Solution for Gyrolab®, EndonucleaseGTP® Solution for Gyrolab®, and CHO HCP 3G Solution for Gyrolab®